These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9622114)

  • 1. Measurement of the upper limit of vulnerability during defibrillator implantation can substitute defibrillation threshold measurement.
    Bessho R; Tanaka S
    Int J Artif Organs; 1998 Mar; 21(3):151-60. PubMed ID: 9622114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing.
    Green UB; Garg A; Al-Kandari F; Ungab G; Tone L; Feld GK
    J Interv Card Electrophysiol; 2003 Feb; 8(1):71-5. PubMed ID: 12652181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm.
    Birgersdotter-Green U; Undesser K; Fujimura O; Feld GK; Kass RM; Mandel WJ; Peter CT; Chen PS
    J Interv Card Electrophysiol; 1999 Jul; 3(2):155-61. PubMed ID: 10387143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs.
    Swerdlow CD; Shehata M; Chen PS
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):258-70. PubMed ID: 17338725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
    Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Cardiac Vulnerability and Restitution Properties of the Ventricular Activation Recovery Interval.
    Yamashita S; Yoshida A; Fukuzawa K; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hyogo K; Imada H; Hirata K
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):768-73. PubMed ID: 25810143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions.
    Glikson M; Gurevitz OT; Trusty JM; Sharma V; Luria DM; Eldar M; Shen WK; Rea RF; Hammill SC; Friedman PA
    Am J Cardiol; 2004 Dec; 94(11):1445-9. PubMed ID: 15566924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal strength and number of shocks at upper limit of vulnerability testing required to predict high defibrillation threshold without inducing ventricular fibrillation.
    Takami K; Yoshida A; Fukuzawa K; Takei A; Kiuchi K; Kanda G; Kumagai H; Takami M; Torii-Tanaka S; Itoh M; Imamura K; Fujiwara R; Suzuki A; Nakanishi T; Yamashita S; Matsumoto A; Hirata K
    Circ J; 2013; 77(10):2490-6. PubMed ID: 23877733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate reproducibility of upper limit of vulnerability measurements in patients undergoing transvenous implantable cardioverter defibrillator implantation.
    Ellenbogen KA; Wood MA; Gilligan DM; Crofts T; London W; McClish D
    J Cardiovasc Electrophysiol; 1998 Jun; 9(6):588-95. PubMed ID: 9654223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancies between the upper limit of vulnerability and defibrillation threshold: prevalence and clinical predictors.
    Gurevitz OT; Friedman PA; Glikson M; Trusty JM; Ballman KV; Rosales AG; Hayes DL; Hammill SC; Swerdlow CD
    J Cardiovasc Electrophysiol; 2003 Jul; 14(7):728-32. PubMed ID: 12930253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper limit of vulnerability predicts chronic defibrillation threshold for transvenous implantable defibrillators.
    Martin DJ; Chen PS; Hwang C; Gang ES; Mandel WJ; Peter CT; Swerdlow CD
    J Cardiovasc Electrophysiol; 1997 Mar; 8(3):241-8. PubMed ID: 9083873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing--The Prospective, Randomized, Multicentre TropShock-Trial.
    Semmler V; Biermann J; Haller B; Jilek C; Sarafoff N; Lennerz C; Vrazic H; Zrenner B; Asbach S; Kolb C
    PLoS One; 2015; 10(7):e0131570. PubMed ID: 26208329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
    Hohnloser SH; Dorian P; Roberts R; Gent M; Israel CW; Fain E; Champagne J; Connolly SJ
    Circulation; 2006 Jul; 114(2):104-9. PubMed ID: 16818810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of adequate safety margin using single coupling interval-upper limit of vulnerability test.
    Patel MB; Pandya K; Thakur RK
    Pacing Clin Electrophysiol; 2014 Jan; 37(1):95-103. PubMed ID: 24033830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper limit of vulnerability reliably predicts the defibrillation threshold in humans.
    Hwang C; Swerdlow CD; Kass RM; Gang ES; Mandel WJ; Peter CT; Chen PS
    Circulation; 1994 Nov; 90(5):2308-14. PubMed ID: 7955188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the upper limit of vulnerability using implantable cardioverter-defibrillator electrograms.
    Swerdlow C; Shivkumar K; Zhang J
    Circulation; 2003 Jun; 107(24):3028-33. PubMed ID: 12810611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term amiodarone treatment on ventricular-fibrillation vulnerability and defibrillation efficacy in response to monophasic and biphasic shocks.
    Behrens S; Li C; Franz MR
    J Cardiovasc Pharmacol; 1997 Oct; 30(4):412-8. PubMed ID: 9335398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved defibrillation efficacy with an ascending ramp waveform in humans.
    Shorofsky SR; Rashba E; Havel W; Belk P; Degroot P; Swerdlow C; Gold MR
    Heart Rhythm; 2005 Apr; 2(4):388-94. PubMed ID: 15851341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper limit of vulnerability during defibrillator implantations predicts the occurrence of appropriate shock therapy for ventricular fibrillation.
    Yamashita S; Yoshida A; Fukuzawa K; Fujiwara R; Suzuki A; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hirata K
    Circ J; 2014; 78(7):1606-11. PubMed ID: 24817761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative reproducibility of defibrillation threshold and upper limit of vulnerability.
    Swerdlow CD; Davie S; Ahern T; Chen PS
    Pacing Clin Electrophysiol; 1996 Dec; 19(12 Pt 1):2103-11. PubMed ID: 8994950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.